Registro:

Referencias:

• Ahn, T., Yun, C.H., Molecular mechanisms regulating the mitochondrial targeting of microsomal cytochrome P450 enzymes (2010) Curr. Drug Metab., 11 (10), pp. 830-838. , 21208176
• Anandatheerthavarada, H.K., Addya, S., Dwivedi, R.S., Biswas, G., Mullick, J., Avadhani, N.G., Localization of multiple forms of inducible cytochromes P450 in rat liver mitochondria: Immunological characteristics and patterns of xenobiotic substrate metabolism (1997) Arch. Biochem. Biophys., 339, pp. 136-150. , 9056243
• Avadhani, N.G., Sangar, M.C., Bansal, S., Bajpai, P., Bimodal targeting of cytochrome P450s to endoplasmic reticulum and mitochondria: The concept of chimeric signals (2011) FEBS J., 278 (22), pp. 4218-4229. , 21929726
• Batlle, A. 1997. Porfirias y Porfirinas. Aspectos Clínicos, Bioquímicos y Biología Molecular (Federación Bioquímica de la Provincia de Buenos Aires, ed) Acta Bioquím. Clin. Latinoam. Suppl N° 3; Bradford, M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding (1976) Anal. Biochem., 72, pp. 248-254. , 942051
• Buzaleh, A.M., Vázquez, E., Enríquez De Salamanca, R., Batlle, A., An overview on Anesthesia and Porphyrias (Review) (1997) Endocrinol. Metab., 4, pp. 267-279
• Correia, M.A., Sinclair, P.R., De Matteis, F., Cytochrome P450 regulation: The interplay between its heme and apoprotein moieties in synthesis, assembly, repair and disposal (2011) Drug Metab. Rev., 43 (1), pp. 1-26. , 20860521
• Elewski, B., Tavakkol, A., Safety and tolerability of oral antifungal agents in the treatment of fungal nail disease: A proven reality (2005) Ther. Clin. Risk Manag., 1 (4), pp. 299-306. , 18360572
• Ferguson, C.S., Tyndale, R.F., Cytochrome P450 enzymes in the brain: Emerging evidence of biological significance (2011) Trends Pharmacol. Sci., 32, pp. 708-714. , 21975165
• Genter, M.B., Clay, C.D., Dalton, T.P., Dong, H., Nebert, D.W., Shertzr, H., Comparison of mouse hepatic mitochondrial versus microsomal cytochromes P450 following TCDD treatment (2006) Biochem. Biophys. Res. Commun., 342, pp. 1375-1381. , 16516144
• Gervasini, G., Carrillo, J.A., Benitez, J., Potential role of cerebral cytochrome P450 in clinical pharmacokinetics (2004) Clin. Pharmacokinet., 43, pp. 693-706. , 15301574
• Guengerich, F.P., Cheng, Q., Orphans in the human cytochrome P450 superfamily: Approaches to discovering functions and relevance in pharmacology (2011) Pharmacol. Rev., 63 (3), pp. 684-699. , 21737533
• Handschin, C., Meyer, U., Induction of drug metabolism: The role of nuclear receptors (2003) Pharmacol. Rev., 55, pp. 649-673. , 14657421
• Hewitt, N.J., Lecluyse, E.L., Ferguson, S.S., Induction of hepatic cytochrome P450 enzymes: Methods, mechanisms, recommendations, and in vitro-in vivo correlations (2007) Xenobiotica, 37 (1011), pp. 1196-1224. , 17968743
• Hift, R.J., Thunell, S., Brun, A., Drugs in porphyria: From observation to a modern algorithm-based system for the prediction of porphyrogenicity (2011) Pharmacol. Ther., 132 (2), pp. 158-169. , 21704073
• Kerstin, M.E., Ringle, M., Bernhardt, R., Adrenodoxin-A Versatile Ferredoxin (2012) IUBMB Life, 64 (6), pp. 506-512. , 22556163
• Knockaert, L., Fromenty, B., Robin, M.A., Mechanisms of mitochondrial targeting of cytochrome P450 2E1: Physiopathological role in liver injury and obesity (2011) FEBS J., 278 (22), pp. 4252-4260. , 21929725
• Lavandera, J., Batlle, A., Buzaleh, A.M., Metabolization of porphyrinogenic agents in brain: Involvement of the Phase i drug metabolizing system (2007) A Comparative Study in Liver and Kidney. Cell. Mol. Neurobiol., 27, pp. 717-729. , 17676386
• Martínez, M.D.C., Buzaleh, A.M., Del, C., Batlle, A., Efecto de la administración de los anestésicos Enflurano e Isoflurano a ratones con niveles inducidos y deprimidos de Citocromo P450 (2000) Estudios Sobre El Sistema Enzimático Metabolizante de Drogas. Acta Bioquím. Clin. Latinoam., 39, pp. 37-42
• Miksys, S., Tyndale, R.F., Cytochrome P450-mediated drug metabolism in the brain (2013) J. Psychiatry Neurosci., 38 (3), pp. 152-163. , 23199531
• Miksys, S., Hoffman, E., Tyndale, R.F., Regional and cellular induction of nicotine-metabolizing CYP2B1 in rat brain by chronic nicotine treatment (2000) Biochem. Pharmacol., 59, pp. 1501-1511. , 10799646
• Omura, T., Structural diversity of cytochrome P450 enzyme system (2010) J. Biochem., 147 (3), pp. 297-306. , 20068028
• Ortiz De Montellano, P.R., Nelson, S.D., Rearrangement reactions catalyzed by Cytochrome P450s (2011) Arch. Biochem. Biophys., 507 (1), pp. 95-110. , 20971058
• Parera, V.E., De Siervi, A., Varela, L., Rossetti, M.V., Batlle, A.M., Acute porphyrias in the Argentinean population: A review (2003) Cell. Mol. Biol. (Noisy-le-grand), 49 (4), pp. 493-500. , 12899439
• Piñeiro Pauwels, M.B., Gerez, E.N., Martinez, M.C., Melito, V.A., Parera, V.E., Batlle, A., Rossetti, M.V., An odd case of heteroallelic acute intermittent porphyria in the Argentinean population (2013) Cell. Mol. Biol., 59, pp. 1855-OL1860. , (Noisy-le-grand), 23522335
• Reinke, L.A., Moyer, M.J., P-Nitrophenol hydroxylation (1985) A Microsomal Oxidation Which is Highly Inducible by Ethanol. Drug Metab. Dispos., 13 (5), pp. 548-552. , 2865101
• Riddick, D.S., Ding, X., Wolf, C.R., Porter, T.D., Pandey, A.V., Zhang, Q.Y., NADPH-cytochrome P450 oxidoreductase: Roles in physiology, pharmacology, and toxicology (2013) Drug Metab. Dispos., 41, pp. 12-23. , 23086197
• Sanchez-Catalan, M.J., Hipólito, L., Guerri, C., Granero, L., Polache, A., Distribution and differential induction of CYP2E1 by ethanol and acetone in the mesocorticolimbic system of rat (2008) Alcohol Alcohol., 43, pp. 401-407. , 18326880
• Schilter, B., Andersen, M.R., Acharya, C., Omiecinski, C.J., Activation of cytochrome P450 gene expression in the rat brain by phenobarbital-like inducers (2000) J. Pharmacol. Exper. Ther., 294 (3), pp. 916-922. , 10945841
• Schoedel, K.A., Sellers, E.M., Tyndale, R.F., Induction of CYP2B1/2 and nicotine metabolism by ethanol in rat liver but not rat brain (2001) Biochem. Pharmacol., 62, pp. 1025-1036. , 11597571
• Upadhya, S.C., Chinta, S.J., Pai, H.V., Boyd, M.R., Ravindranath, V., Toxicological consequences of differential regulation of cytochrome P450 isoforms in rat brain regions by phenobarbital (2002) Arch. Biochem. Biophys., 399, pp. 56-65. , 11883903
• Wang, X.J., Chamberlain, M., Vassieva, O., Henderson, C.J., Wolf, C.R., Relationship between hepatic phenotype and changes in gene expression in cytochrome P450 reductase (POR) null mice (2005) Biochem. J., 388, pp. 857-867. , 15717863
• Welinder, C., Ekblad, L., Coomassie staining as loading control in Western blot analysis (2011) J. Proteome Res., 10, pp. 1416-1419. , 21186791
• Wong, S.G., Lin, E.H., Marks, G.S., Cytochrome CYP sources of N-alkylprotoporphyrin IX after administration of porphyrinogenic xenobiotics (1999) Drug Metab. Dispos., 27, pp. 960-965. , 10460791

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------